France

Damages, Enforcement, France, Injunction, Procedure

(Véron & Associés)/

Thanks to the constitutional revision of 23 July 2008 (which created Article 61-1 and amended Article 62 of the French Constitution), a new procedure to control the constitutionality of laws was introduced into French law, which came into force on 1st March 2010: the “priority question on constitutionality” (“question prioritaire de constitutionnalité”). Before this reform, the constitutionality could only be verified…

(Indirect) infringement, Case Law, Equivalents, France

(Pinsent Masons)/

The French Supreme Court specified the rules for the application of the doctrine of equivalence in the assessment of infringement of a process patent, holding that a patented process is considered to be infringed under the doctrine of equivalence when both means have the same function in order to obtain the same result as the…

European Union, France, Injunction, Procedure, SPC

(Véron & Associés)/

On 8 June 2012, the Tribunal de Grande Instance of Paris rendered an interesting decision concerning Losartan. It particularly deals with two questions: the conditions of the SPC’s paediatric extension (Regulation (EC) No. 1901/2006) and the preliminary injunction as organized by Article L. 615-3 (implementing Article 9 of Directive (EC) No. 2004/48) of the French Intellectual Property Code. The US company E.I….

Case Law, France, Mechanical Engineering, Procedure

(Pinsent Masons)/

Regarding the gathering of evidence in French and foreign territories, the Paris Court of Appeal affirmed the appealed decision and acceded to defendant’s reasoning in ruling that (i) the ‘saisie-contrefaçon’ carried out on French territory on the basis of two patents was not deprived of its valid basis by the revocation of one of said…

Case Law, France, Procedure

(Pinsent Masons)/

The French Supreme Court for the first time recognized, as a general principle of French patent law, the estoppel “according to which a person may not contradict themselves to the detriment of another person” in the course of infringement proceedings. Click here for the full text of this case. A summary of this case will…

(Indirect) infringement, Chemical Engineering, EPC, Exceptions to patentability, France, Inventive step, Novelty, Revocation, Second Medical Use, Sufficiency of disclosure, Validity

(Véron & Associés)/

On 20 March 2012, the Tribunal de Grande Instance of Paris rendered its decision in the case relating to raloxifene, a molecule useful for treating or preventing osteoporosis in post-menopausal women, opposing Teva to Eli Lilly. This decision raises many questions, first concerning drug patents in particular (patentability of second medical use, patentability of the resolution of…

Damages, France, Germany, Netherlands, Procedure, Revocation, United Kingdom

(Véron & Associés)/

Mr X was ordered to pay damages for the infringement of a French patent No. 87‑03865, relating to a massage device, by a decision of the Cour d’Appel of Limoges on 10 September 2001. In the absence of an appeal on a point of law, this decision became irrevocable. However, in a separate action, the same patent was subsequently…

Damages, Enforcement, France, Injunction, Procedure, Revocation

(Véron & Associés)/

Laboratoires Negma (hereinafter referred to as “Negma”) is the exclusive licensee of European patent No. 0 520 414 which relates to a method for the preparation of diacetylrhein (also called diacerein) having a specific degree of purity as well as diacetylrhein obtained by this process and a pharmaceutical composition containing this compound. Such European patent was first filed…